Mary Hamby

Company: Cognition Therapeutics Inc

Job title: Vice President - Research

Seminars:

Roundtable Discussion: Identifying Patient-Derived Biomarkers through Lipid Signatures from Non-Invasive Patient Samples for Earlier Detection of Neurodegeneration 11:00 am

Assessing early PK/PD relationship to inform early trial dynamics of markers Integrating blood based biomarkers, clinical presentation, patient history and imaging for more streamlined patient diagnosis Harnessing biofluids for less invasive diagnosis, staging and prediction of treatment response in patientsRead more

day: Blood-Based Biomarker Focus Day

Proof of Mechanism that Investigational Therapeutic CT1812 Impacts Key Alzheimer’s Disease Biologies 10:30 am

Pharmacodynamic biomarkers of CT1812 identified Unbiased pathway analysis shows support that CT1812 is impacting synaptic biology, amyloid biology and neuroinflammation Correlates to functional or clinical outcome measures identified to support a favourable clinical impact of CT1812 Comparative analysis shows replication across independent clinical cohortsRead more

day: Blood-Based Biomarker Focus Day

Panel Discussion: Overcoming Barriers to Clinical Utility of Emerging Non-Invasive Blood & Imaging Tests 3:00 pm

Navigating accessibility challenges internationally to blood based biomarkers for early diagnosis Employing consortia to strategically make biomarkers more reliable, generalizable and clinically relevant to enhance the quality and credibility of biomarker validation studies Exploring future directions in biofluid sampling at-home for improved patient experience and retention in clinical trialRead more

day: Blood-Based Biomarker Focus Day